heart disease
Conditions
Interventions
Remazolam group (Age 2-8):Remimazolam 0.3 mg·kg-1 for anesthesia induction and 1 mg·kg-1·h-1 for maintenance
Propofol group (Age 2-8):Propofol was used for induction of anesthesia at 3 mg·kg-1 and 8 mg·kg-1·h-1 for maintenance.
Remazolam group (Age 65-80):Remimazolam 0.3 mg·kg-1 for anesthesia induction and 1 mg·kg-1·h-1 for maintenance
Propofol group (Age 65-80):Propofol was used for induction of anesthesia at 3 mg·kg-1 and 8 mg·kg-1·h-1 for maintenance.
Sponsors
Central China Fu Wai Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Age
2 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Age 2-8 years; 2) Children who are scheduled to undergo interventional surgery for congenital heart disease under general fast-track anesthesia; 3) Age 65-80 years; 4) Elderly patients who are scheduled to undergo interventional surgery for congenital heart disease under general fast-track anesthesia; 5) Voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1) Children with cyanotic complex congenital heart disease; 2) Combined with other congenital diseases; 3) Patients who have previously undergone intracardiac intervention or surgical recurrence and need interventional treatment again; 4) Patients with communication disorders, including language and hearing disorders, and those unable to understand Mandarin; 5) Patients who are allergic or may be allergic to the study drug; 6) Participation in other clinical investigators within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to extubation;Time of loss of consciousness;Number of sedation failures, etc.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative consciousness score;Hospitalization days; | — |
Countries
China
Contacts
Public ContactPengyu Qin
Henan Provincial People’s Hospital, Department of Anesthesia of central China Fu Wai Hospital of Zhengzhou University
Outcome results
None listed